Functional Biomarkers for Cardiometabolic Disorders
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: closed (30 November 2023) | Viewed by 361
Special Issue Editor
Interests: cardiovascular disease; innovative diagnostics; disease prevention strategies
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cardiometabolic disorders are a set of maladaptive cardiovascular, renal, thrombotic, inflammatory, and metabolic diseases, long been recognized by worldwide health organizations. Cardiometabolic disorders are the leading cause of mortality globally. Identifying novel and early-stage biomarkers of cardiovascular disorders is critical for predicting and avoiding the considerable morbidity and mortality associated with these diseases. The number of possible biomarkers that allow for the improved functional characterization of individuals with cardiometabolic disorders is constantly expanding. New biomarkers for cardiovascular and metabolic disease characterization are being developed by combining continuous physiological signal detection with various analytic approaches. Functional biomarkers can be derived from wearable devices or sequential measures with point-of-care devices to boost early disease detection, disease status surveillance, and therapy efficacy. Furthermore, systems biology approaches have the potential to identify biomarkers for diagnostic, prognostic, or predictive purposes.
With this Special Issue, we aim to gather insights on promising functional biomarkers with diagnostic, predictive, prognostic, and therapeutic significance for cardiometabolic disorders and to support decision making in clinical studies.
Prof. Dr. Ovidiu Constantin Baltatu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
